Hepatic Encephalopathy Drug Market, Global Outlook and Forecast 2022-2028

March 2022 | 79 pages | ID: HCCBE4E39A2CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Hepatic Encephalopathy Drug in global, including the following market information:

Global Hepatic Encephalopathy Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Hepatic Encephalopathy Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)

Global top five Hepatic Encephalopathy Drug companies in 2021 (%)

The global Hepatic Encephalopathy Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

RBX-2660 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hepatic Encephalopathy Drug include Alfa Wassermann S.p.A, Cosmo Pharmaceuticals S.p.A, Horizon Pharma Plc, KannaLife Sciences, Inc., Ocera Therapeutics, Inc., Rebiotix Inc., Spherium Biomed S.L. and Umecrine Cognition AB, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatic Encephalopathy Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hepatic Encephalopathy Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Hepatic Encephalopathy Drug Market Segment Percentages, by Type, 2021 (%)

• RBX-2660
• KLS-13019
• GR-3027
• SYNB-1020
• Others

Global Hepatic Encephalopathy Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Hepatic Encephalopathy Drug Market Segment Percentages, by Application, 2021 (%)

• Clinic
• Hospital
• Others

Global Hepatic Encephalopathy Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Hepatic Encephalopathy Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hepatic Encephalopathy Drug revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Hepatic Encephalopathy Drug revenues share in global market, 2021 (%)

Key companies Hepatic Encephalopathy Drug sales in global market, 2017-2022 (Estimated), (K Pcs)

Key companies Hepatic Encephalopathy Drug sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Alfa Wassermann S.p.A
• Cosmo Pharmaceuticals S.p.A
• Horizon Pharma Plc
• KannaLife Sciences, Inc.
• Ocera Therapeutics, Inc.
• Rebiotix Inc.
• Spherium Biomed S.L.
• Umecrine Cognition AB

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hepatic Encephalopathy Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hepatic Encephalopathy Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEPATIC ENCEPHALOPATHY DRUG OVERALL MARKET SIZE

2.1 Global Hepatic Encephalopathy Drug Market Size: 2021 VS 2028
2.2 Global Hepatic Encephalopathy Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Hepatic Encephalopathy Drug Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Hepatic Encephalopathy Drug Players in Global Market
3.2 Top Global Hepatic Encephalopathy Drug Companies Ranked by Revenue
3.3 Global Hepatic Encephalopathy Drug Revenue by Companies
3.4 Global Hepatic Encephalopathy Drug Sales by Companies
3.5 Global Hepatic Encephalopathy Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Hepatic Encephalopathy Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Hepatic Encephalopathy Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatic Encephalopathy Drug Players in Global Market
  3.8.1 List of Global Tier 1 Hepatic Encephalopathy Drug Companies
  3.8.2 List of Global Tier 2 and Tier 3 Hepatic Encephalopathy Drug Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Hepatic Encephalopathy Drug Market Size Markets, 2021 & 2028
  4.1.2 RBX-2660
  4.1.3 KLS-13019
  4.1.4 GR-3027
  4.1.5 SYNB-1020
  4.1.6 Others
4.2 By Type - Global Hepatic Encephalopathy Drug Revenue & Forecasts
  4.2.1 By Type - Global Hepatic Encephalopathy Drug Revenue, 2017-2022
  4.2.2 By Type - Global Hepatic Encephalopathy Drug Revenue, 2023-2028
  4.2.3 By Type - Global Hepatic Encephalopathy Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Hepatic Encephalopathy Drug Sales & Forecasts
  4.3.1 By Type - Global Hepatic Encephalopathy Drug Sales, 2017-2022
  4.3.2 By Type - Global Hepatic Encephalopathy Drug Sales, 2023-2028
  4.3.3 By Type - Global Hepatic Encephalopathy Drug Sales Market Share, 2017-2028
4.4 By Type - Global Hepatic Encephalopathy Drug Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hepatic Encephalopathy Drug Market Size, 2021 & 2028
  5.1.2 Clinic
  5.1.3 Hospital
  5.1.4 Others
5.2 By Application - Global Hepatic Encephalopathy Drug Revenue & Forecasts
  5.2.1 By Application - Global Hepatic Encephalopathy Drug Revenue, 2017-2022
  5.2.2 By Application - Global Hepatic Encephalopathy Drug Revenue, 2023-2028
  5.2.3 By Application - Global Hepatic Encephalopathy Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Hepatic Encephalopathy Drug Sales & Forecasts
  5.3.1 By Application - Global Hepatic Encephalopathy Drug Sales, 2017-2022
  5.3.2 By Application - Global Hepatic Encephalopathy Drug Sales, 2023-2028
  5.3.3 By Application - Global Hepatic Encephalopathy Drug Sales Market Share, 2017-2028
5.4 By Application - Global Hepatic Encephalopathy Drug Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hepatic Encephalopathy Drug Market Size, 2021 & 2028
6.2 By Region - Global Hepatic Encephalopathy Drug Revenue & Forecasts
  6.2.1 By Region - Global Hepatic Encephalopathy Drug Revenue, 2017-2022
  6.2.2 By Region - Global Hepatic Encephalopathy Drug Revenue, 2023-2028
  6.2.3 By Region - Global Hepatic Encephalopathy Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Hepatic Encephalopathy Drug Sales & Forecasts
  6.3.1 By Region - Global Hepatic Encephalopathy Drug Sales, 2017-2022
  6.3.2 By Region - Global Hepatic Encephalopathy Drug Sales, 2023-2028
  6.3.3 By Region - Global Hepatic Encephalopathy Drug Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Hepatic Encephalopathy Drug Revenue, 2017-2028
  6.4.2 By Country - North America Hepatic Encephalopathy Drug Sales, 2017-2028
  6.4.3 US Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.4.4 Canada Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.4.5 Mexico Hepatic Encephalopathy Drug Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Hepatic Encephalopathy Drug Revenue, 2017-2028
  6.5.2 By Country - Europe Hepatic Encephalopathy Drug Sales, 2017-2028
  6.5.3 Germany Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.5.4 France Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.5.5 U.K. Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.5.6 Italy Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.5.7 Russia Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.5.8 Nordic Countries Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.5.9 Benelux Hepatic Encephalopathy Drug Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Hepatic Encephalopathy Drug Revenue, 2017-2028
  6.6.2 By Region - Asia Hepatic Encephalopathy Drug Sales, 2017-2028
  6.6.3 China Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.6.4 Japan Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.6.5 South Korea Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.6.6 Southeast Asia Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.6.7 India Hepatic Encephalopathy Drug Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Hepatic Encephalopathy Drug Revenue, 2017-2028
  6.7.2 By Country - South America Hepatic Encephalopathy Drug Sales, 2017-2028
  6.7.3 Brazil Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.7.4 Argentina Hepatic Encephalopathy Drug Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Hepatic Encephalopathy Drug Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Hepatic Encephalopathy Drug Sales, 2017-2028
  6.8.3 Turkey Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.8.4 Israel Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.8.5 Saudi Arabia Hepatic Encephalopathy Drug Market Size, 2017-2028
  6.8.6 UAE Hepatic Encephalopathy Drug Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Alfa Wassermann S.p.A
  7.1.1 Alfa Wassermann S.p.A Corporate Summary
  7.1.2 Alfa Wassermann S.p.A Business Overview
  7.1.3 Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Major Product Offerings
  7.1.4 Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales and Revenue in Global (2017-2022)
  7.1.5 Alfa Wassermann S.p.A Key News
7.2 Cosmo Pharmaceuticals S.p.A
  7.2.1 Cosmo Pharmaceuticals S.p.A Corporate Summary
  7.2.2 Cosmo Pharmaceuticals S.p.A Business Overview
  7.2.3 Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Major Product Offerings
  7.2.4 Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales and Revenue in Global (2017-2022)
  7.2.5 Cosmo Pharmaceuticals S.p.A Key News
7.3 Horizon Pharma Plc
  7.3.1 Horizon Pharma Plc Corporate Summary
  7.3.2 Horizon Pharma Plc Business Overview
  7.3.3 Horizon Pharma Plc Hepatic Encephalopathy Drug Major Product Offerings
  7.3.4 Horizon Pharma Plc Hepatic Encephalopathy Drug Sales and Revenue in Global (2017-2022)
  7.3.5 Horizon Pharma Plc Key News
7.4 KannaLife Sciences, Inc.
  7.4.1 KannaLife Sciences, Inc. Corporate Summary
  7.4.2 KannaLife Sciences, Inc. Business Overview
  7.4.3 KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Major Product Offerings
  7.4.4 KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales and Revenue in Global (2017-2022)
  7.4.5 KannaLife Sciences, Inc. Key News
7.5 Ocera Therapeutics, Inc.
  7.5.1 Ocera Therapeutics, Inc. Corporate Summary
  7.5.2 Ocera Therapeutics, Inc. Business Overview
  7.5.3 Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Major Product Offerings
  7.5.4 Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales and Revenue in Global (2017-2022)
  7.5.5 Ocera Therapeutics, Inc. Key News
7.6 Rebiotix Inc.
  7.6.1 Rebiotix Inc. Corporate Summary
  7.6.2 Rebiotix Inc. Business Overview
  7.6.3 Rebiotix Inc. Hepatic Encephalopathy Drug Major Product Offerings
  7.6.4 Rebiotix Inc. Hepatic Encephalopathy Drug Sales and Revenue in Global (2017-2022)
  7.6.5 Rebiotix Inc. Key News
7.7 Spherium Biomed S.L.
  7.7.1 Spherium Biomed S.L. Corporate Summary
  7.7.2 Spherium Biomed S.L. Business Overview
  7.7.3 Spherium Biomed S.L. Hepatic Encephalopathy Drug Major Product Offerings
  7.7.4 Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales and Revenue in Global (2017-2022)
  7.7.5 Spherium Biomed S.L. Key News
7.8 Umecrine Cognition AB
  7.8.1 Umecrine Cognition AB Corporate Summary
  7.8.2 Umecrine Cognition AB Business Overview
  7.8.3 Umecrine Cognition AB Hepatic Encephalopathy Drug Major Product Offerings
  7.8.4 Umecrine Cognition AB Hepatic Encephalopathy Drug Sales and Revenue in Global (2017-2022)
  7.8.5 Umecrine Cognition AB Key News

8 GLOBAL HEPATIC ENCEPHALOPATHY DRUG PRODUCTION CAPACITY, ANALYSIS

8.1 Global Hepatic Encephalopathy Drug Production Capacity, 2017-2028
8.2 Hepatic Encephalopathy Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatic Encephalopathy Drug Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 HEPATIC ENCEPHALOPATHY DRUG SUPPLY CHAIN ANALYSIS

10.1 Hepatic Encephalopathy Drug Industry Value Chain
10.2 Hepatic Encephalopathy Drug Upstream Market
10.3 Hepatic Encephalopathy Drug Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Hepatic Encephalopathy Drug Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Hepatic Encephalopathy Drug in Global Market
Table 2. Top Hepatic Encephalopathy Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Hepatic Encephalopathy Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Hepatic Encephalopathy Drug Revenue Share by Companies, 2017-2022
Table 5. Global Hepatic Encephalopathy Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Hepatic Encephalopathy Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Hepatic Encephalopathy Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Hepatic Encephalopathy Drug Product Type
Table 9. List of Global Tier 1 Hepatic Encephalopathy Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatic Encephalopathy Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Hepatic Encephalopathy Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Hepatic Encephalopathy Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Hepatic Encephalopathy Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Hepatic Encephalopathy Drug Sales (K Pcs), 2023-2028
Table 16. By Application – Global Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Hepatic Encephalopathy Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Hepatic Encephalopathy Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Hepatic Encephalopathy Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Hepatic Encephalopathy Drug Sales (K Pcs), 2023-2028
Table 21. By Region – Global Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Hepatic Encephalopathy Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Hepatic Encephalopathy Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Hepatic Encephalopathy Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Hepatic Encephalopathy Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Hepatic Encephalopathy Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Hepatic Encephalopathy Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Hepatic Encephalopathy Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Hepatic Encephalopathy Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Hepatic Encephalopathy Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Hepatic Encephalopathy Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Hepatic Encephalopathy Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Hepatic Encephalopathy Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Hepatic Encephalopathy Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Hepatic Encephalopathy Drug Sales, (K Pcs), 2023-2028
Table 46. Alfa Wassermann S.p.A Corporate Summary
Table 47. Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Product Offerings
Table 48. Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Cosmo Pharmaceuticals S.p.A Corporate Summary
Table 50. Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Product Offerings
Table 51. Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Horizon Pharma Plc Corporate Summary
Table 53. Horizon Pharma Plc Hepatic Encephalopathy Drug Product Offerings
Table 54. Horizon Pharma Plc Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. KannaLife Sciences, Inc. Corporate Summary
Table 56. KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Product Offerings
Table 57. KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Ocera Therapeutics, Inc. Corporate Summary
Table 59. Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Product Offerings
Table 60. Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Rebiotix Inc. Corporate Summary
Table 62. Rebiotix Inc. Hepatic Encephalopathy Drug Product Offerings
Table 63. Rebiotix Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Spherium Biomed S.L. Corporate Summary
Table 65. Spherium Biomed S.L. Hepatic Encephalopathy Drug Product Offerings
Table 66. Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Umecrine Cognition AB Corporate Summary
Table 68. Umecrine Cognition AB Hepatic Encephalopathy Drug Product Offerings
Table 69. Umecrine Cognition AB Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Hepatic Encephalopathy Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 71. Global Hepatic Encephalopathy Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Hepatic Encephalopathy Drug Production by Region, 2017-2022 (K Pcs)
Table 73. Global Hepatic Encephalopathy Drug Production by Region, 2023-2028 (K Pcs)
Table 74. Hepatic Encephalopathy Drug Market Opportunities & Trends in Global Market
Table 75. Hepatic Encephalopathy Drug Market Drivers in Global Market
Table 76. Hepatic Encephalopathy Drug Market Restraints in Global Market
Table 77. Hepatic Encephalopathy Drug Raw Materials
Table 78. Hepatic Encephalopathy Drug Raw Materials Suppliers in Global Market
Table 79. Typical Hepatic Encephalopathy Drug Downstream
Table 80. Hepatic Encephalopathy Drug Downstream Clients in Global Market
Table 81. Hepatic Encephalopathy Drug Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Hepatic Encephalopathy Drug Segment by Type
Figure 2. Hepatic Encephalopathy Drug Segment by Application
Figure 3. Global Hepatic Encephalopathy Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatic Encephalopathy Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatic Encephalopathy Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Hepatic Encephalopathy Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Hepatic Encephalopathy Drug Revenue in 2021
Figure 9. By Type - Global Hepatic Encephalopathy Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Hepatic Encephalopathy Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Hepatic Encephalopathy Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Hepatic Encephalopathy Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Hepatic Encephalopathy Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Hepatic Encephalopathy Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Hepatic Encephalopathy Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Hepatic Encephalopathy Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Hepatic Encephalopathy Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Hepatic Encephalopathy Drug Sales Market Share, 2017-2028
Figure 19. US Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Hepatic Encephalopathy Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Hepatic Encephalopathy Drug Sales Market Share, 2017-2028
Figure 24. Germany Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Hepatic Encephalopathy Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Hepatic Encephalopathy Drug Sales Market Share, 2017-2028
Figure 33. China Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Hepatic Encephalopathy Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Hepatic Encephalopathy Drug Sales Market Share, 2017-2028
Figure 40. Brazil Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Hepatic Encephalopathy Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Hepatic Encephalopathy Drug Sales Market Share, 2017-2028
Figure 44. Turkey Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Hepatic Encephalopathy Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Hepatic Encephalopathy Drug by Region, 2021 VS 2028
Figure 50. Hepatic Encephalopathy Drug Industry Value Chain
Figure 51. Marketing Channels